Optimal diuretic strategies in heart failure

被引:8
|
作者
Suri, Sarabjeet S. [1 ]
Pamboukian, Salpy V. [1 ]
机构
[1] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA
关键词
Heart failure (HF); diuresis; diuretic resistance; FUROSEMIDE; TOLVAPTAN;
D O I
10.21037/atm-20-4600
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Heart failure (HF) is one of the major causes of morbidity and mortality in the world. According to a 2019 American Heart Association report, about 6.2 million American adults had HF between 2013 and 2016, being responsible for almost 1 million admissions. As the population ages, the prevalence of HF is anticipated to increase, with 8 million Americans projected to have HF by 2030, posing a significant public health and financial burden. Acute decompensated HF (ADHF) is a syndrome characterized by volume overload and inadequate cardiac output associated with symptoms including some combination of exertional shortness of breath, orthopnea, paroxysmal nocturnal dyspnea (PND), fatigue, tissue congestion (e.g., peripheral edema) and decreased mentation. The pathology is characterized by hemodynamic abnormalities that result in autonomic imbalance with an increase in sympathetic activity, withdrawal of vagal activity and neurohormonal activation (NA) resulting in increased plasma volume in the setting of decreased sodium excretion, increased water retention and in turn an elevation of filling pressures. These neurohormonal changes are adaptive mechanisms which in the short term are associated with increased contractility of the left ventricular (LV) and improvement in cardiac output. But chronically, the failing heart is unable to overcome the excessive pressure and volume leading to worsening HF. The primary symptomatic management of ADHF includes intravenous (IV) diuresis to help with decongestion and return to euvolemic status. Even though diuretics have not been shown to provide any mortality benefit, they have been clinically proven to be of significant benefit in the acute decompensated phase, as well as in chronic management of HF. Loop diuretics remain the mainstay of therapy for symptomatic management of HF with use of thiazide diuretics for synergistic effect in the setting of diuretic resistance. Poor diuretic efficacy has been linked with higher mortality and increased rehospitalizations.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Diuretic for managing canine heart failure
    不详
    VETERINARY RECORD, 2015, 177 (06)
  • [32] DIURETIC DRUGS IN CONGESTIVE HEART FAILURE
    RAY, CT
    BRESLER, EH
    MEDICAL CLINICS OF NORTH AMERICA, 1957, 41 (02) : 433 - 447
  • [33] Comparison of three different diuretic treatment strategies in acute decompensated heart failure patients
    Yayla, C.
    Akyel, A.
    Canpolat, U.
    Yayla, K. Gayretli
    Eyiol, A.
    Akboga, M.
    Turkoglu, S.
    Tavil, Y.
    Boyaci, B.
    Cengel, A.
    EUROPEAN HEART JOURNAL, 2017, 38 : 300 - 300
  • [34] Diuretic Use in Heart Failure and Outcomes
    von Lueder, T. G.
    Atar, D.
    Krum, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (04) : 490 - 498
  • [35] Decompensated heart failure and diuretic resistance
    Guntheroth, Warren G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (05) : 1059 - 1060
  • [36] DIURETIC TREATMENT IN HEART-FAILURE
    PIPER, C
    MEDIZINISCHE WELT, 1989, 40 (11): : 310 - 317
  • [37] Diuretic therapy in congestive heart failure
    Kennelly, Patrick
    Sapkota, Rajju
    Azhar, Maimoona
    Cheema, Faisal Habib
    Conway, Claire
    Hameed, Aamir
    ACTA CARDIOLOGICA, 2022, 77 (02) : 97 - 104
  • [38] DIURETIC THERAPY OF CONGESTIVE HEART FAILURE
    FORD, RV
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1958, 71 (04) : 397 - 408
  • [39] Diuretic Resistance Associated With Heart Failure
    Shams, Elham
    Bonnice, Sabrina
    Mayrovitz, Harvey N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [40] Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: An analysis from Diuretic Optimization Strategies in Acute Heart Failure
    Shah, Ravi V.
    McNulty, Steven
    O'Connor, Christopher M.
    Felker, G. Michael
    Braunwald, Eugene
    Givertz, Michael M.
    AMERICAN HEART JOURNAL, 2012, 164 (06) : 862 - 868